Yanyang Tu

2.2k citations
71 papers · 1.7k indexed · h-index 26
Topics
MicroRNA in disease regulation (14 papers)Glioma Diagnosis and Treatment (12 papers)Cancer-related molecular mechanisms research (10 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONECancer Research
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Yanyang Tu

66 papers receiving 1.7k citations

Peers

Yanyang Tu
Comparison fields: 5 of 101
  • Molecular Biology 1.2k
  • Cancer Research 749
  • Oncology 288
  • Genetics 248
  • Immunology 154
Replace Kiran Kumar Velpula with:
Kiran Kumar Velpula United States
Maode Wang China
Yanhua Zheng China
Mingzhi Han China
Linda J. Metheny‐Barlow United States
Pamela Bielli Italy
Jing Ni United States
Maria Chiara De Santis Italy
Yanyang Tu relative to Kiran Kumar Velpula United States Kiran Kumar Velpula's profile →
Citations per field
00.5×1.5×
Kiran Kumar Velpula · 1×
Citations per year

Countries citing papers authored by Yanyang Tu

Since Specialization
Citations

This map shows the geographic impact of Yanyang Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanyang Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanyang Tu more than expected).

Fields of papers citing papers by Yanyang Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanyang Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanyang Tu. The network helps show where Yanyang Tu may publish in the future.

Co-authorship network of co-authors of Yanyang Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanyang Tu. A scholar is included among the top collaborators of Yanyang Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanyang Tu. Yanyang Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 14
5 46
6 0
7 1
8 5
9 23
10 12
11 67
12 19
13 38
14 58
15 52
16 25
17 21
18 112
19 70
20
Reinforcement of nimodipine to the TK suicide gene therapy of glioma
1

About Yanyang Tu

Yanyang Tu is a scholar working on Cancer Research, Genetics and Molecular Biology, having authored 71 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (14 papers), Glioma Diagnosis and Treatment (12 papers) and Cancer-related molecular mechanisms research (10 papers). The work is most often cited by research in Cancer Research (749 citations), Genetics (248 citations) and Molecular Biology (1.2k citations). Yanyang Tu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shiming He, Liang Wang, Weilin Jin, Gang Li, Xingchun Gao, Hui Liu, Nan Liu, Yongsheng Zhang, Daxiang Cui and Pengxing Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026